<DOC>
	<DOCNO>NCT01058057</DOCNO>
	<brief_summary>This study investigate potential protective effect atorvastatin pre-treatment patient stable coronary artery disease undergo percutaneous coronary intervention ( PCI ) chronic statin therapy . Patients randomize two group : atorvastatin pre-treatment group ( 80mg atorvastatin seven day PCI ) control group ( PCI without atorvastatin pretreatment , chronic statin treatment ) . Endpoint myocardial infarction measure troponin I creatine kinase myocardial band .</brief_summary>
	<brief_title>Atorvastatin Pre-Treatment Influences Risk Percutaneous Coronary Intervention ( PCI ) Study 2</brief_title>
	<detailed_description>This randomize study investigate potential protective effect high dose atorvastatin pre-treatment patient stable coronary artery disease undergo percutaneous coronary intervention ( PCI ) chronic statin therapy . Two arm : 1. atorvastatin pre-treatment group ( 80mg atorvastatin seven day ) 2. control group ( without atorvastatin pre-treatment , chronic statin treatment ) Primary endpoint : Periprocedural myocardial infarction measure troponin I level ( time frame 24 hour ) Secondary endpoint : Periprocedural myocardial infarction measure creatine kinase myocardial band ( time frame 24 hour )</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Indication percutaneous coronary intervention Informed consent Chronic statin therapy Acute coronary syndrome last 14 day Renal insufficiency ( creatinine 150 umol/l ) Diseases severely limiting prognosis Previous participation study Chronic occlusion coronary artery , bypass intervention , leave main intervention Chronic statin treatment atorvastatin 80mg daily rosuvastatin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>atorvastatin</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>periprocedural myocardial infarction</keyword>
	<keyword>Hydroxymethylglutaryl-CoA Reductase Inhibitors</keyword>
</DOC>